HCG for TRT: Doses, Forms & The 2026 Compounding Crisis

HCG for TRT: Doses, Forms & The 2026 Compounding Crisis
Educational use only. This article is informational and does not constitute medical advice. Peptide dosing decisions should be made in consultation with a licensed physician familiar with your medical history. Always verify any dose with your prescribing physician before drawing or administering. Some peptides discussed are not FDA-approved for human use; legal and regulatory status varies by jurisdiction.

Table of Contents

Quick answer: The standard TRT-adjunct HCG dose is 250-500 IU subcutaneous, 2-3 times per week, alongside testosterone replacement therapy. TRT users take HCG to maintain testicular size, preserve fertility, and prevent the mood/cognitive symptoms some men experience when testicular function shuts down on TRT alone.

Important: HCG is dosed in International Units (IU), not milligrams. Confusing the two is the most common reconstitution error and can lead to dosing errors of 100x or more.

The 2026 reality: HCG has become significantly harder to source through compounding pharmacies since FDA enforcement actions in 2024-2025. Many TRT clinics have switched patients to gonadorelin as a result.

FDA status: HCG itself is FDA-approved (brand names: Pregnyl, Novarel) for hypogonadotropic hypogonadism in males, ovulation induction in females, and cryptorchidism in pediatric patients. Use as a TRT adjunct (the focus of this article) is off-label, supported by a long history of clinical practice but not on the FDA-approved label.

What HCG Actually Does

Human Chorionic Gonadotropin is a glycoprotein hormone produced naturally by the placenta during pregnancy. It is a 244-amino-acid peptide hormone composed of two subunits, alpha and beta. The beta subunit is what gives HCG its specific biological identity, and it is why home pregnancy tests work.

In the human body, HCG binds to luteinizing hormone (LH) receptors. That is the key to why it matters for men on testosterone replacement therapy.

When a man starts TRT, the hypothalamic-pituitary-gonadal (HPG) axis shuts down. The brain detects high circulating testosterone and stops producing GnRH (gonadotropin-releasing hormone). Without GnRH, the pituitary stops making LH and FSH. Without LH, the Leydig cells in the testicles stop producing testosterone and the seminiferous tubules slow down sperm production. The testicles atrophy. Fertility declines. Some men report mood changes, libido shifts, or a sense of “feeling off” that exogenous testosterone alone does not fix.

HCG bypasses this shutdown by acting as an LH mimic. Inject HCG subcutaneously, and your Leydig cells light back up like LH was telling them to. Testicular size is maintained. Some intratesticular testosterone production resumes. Sperm production continues, though typically not at pre-TRT levels. The “shut down” feeling many men report on TRT-only protocols often resolves.

Why TRT Users Need It

There are three reasons men take HCG alongside testosterone:

1. Testicular atrophy. Without LH stimulation, the testicles shrink. The change can be significant, with some men reporting 30-50% reduction in testicular volume within months of starting TRT-only. Cosmetically and functionally, most men want to avoid this. HCG prevents it.

2. Fertility preservation. TRT-only protocols suppress sperm production, often to azoospermic (zero sperm) levels within 3-6 months. For men who want to preserve the option of biological children, HCG keeps the spermatogenic machinery operational. Studies suggest fertility on TRT plus HCG ranges from preserved to mildly reduced, vs. severely reduced on TRT alone.

3. Mood and well-being. This one is harder to study but consistently reported. Some percentage of men on TRT-only describe a flat or “off” feeling that does not resolve with dose adjustment. Adding HCG often resolves it. The mechanism is debated, possibly related to intratesticular testosterone (which is much higher than serum testosterone), DHEA-like adrenal support, or pregnenolone pathway effects. The data on this is more anecdotal than the testicular and fertility effects, but it is real enough that many TRT clinicians use it as a default add-on.

Standard Dosing Protocols

TRT adjunct (most common): 250-500 IU subcutaneous, 2-3 times per week. This is the standard. Lower-end (250 IU 2x/week) is sufficient for many users. Higher-end (500 IU 3x/week) is used when fertility preservation is a stronger goal, or when the user has noticeable testicular atrophy at lower doses.

Fertility restart (post-TRT or HPTA recovery): 1,500-3,000 IU 2-3 times per week, often paired with hMG or clomiphene. Heavier dosing, typically supervised by a fertility specialist.

Ovulation trigger (women, fertility treatments): 5,000-10,000 IU as a single dose. Outside the scope of this article but worth noting if you are shopping vials and see “10,000 IU” formulations.

Reconstitution Math: The IU Trap

HCG vials are sold by International Units (IU), not milligrams. A typical compounded vial is 5,000 IU. You reconstitute it with bacteriostatic water (usually 5 mL or 10 mL), then draw your dose in IU.

The math:

If you have a 5,000 IU vial reconstituted with 5 mL of bacteriostatic water:

  • Concentration: 5,000 IU divided by 5 mL = 1,000 IU per mL
  • For a 250 IU dose: 250 / 1,000 = 0.25 mL
  • On a U-100 insulin syringe: 0.25 mL = 25 units

If you reconstitute the same vial with 10 mL instead:

  • Concentration: 500 IU per mL
  • For a 250 IU dose: 0.5 mL = 50 units on a U-100 syringe

The calculator on this site handles HCG specifically. It lets you enter vial size in IU, BAC water in mL, and your target dose in IU, and it spits out the correct mL and U-100 unit volume. Use it. The math is simple but the consequences of a 10x error are not.

The Compounding Crisis

If you started TRT in 2018, getting HCG was easy. Most men’s health clinics had it on the shelf. By 2026, that is no longer the reality.

In 2024, FDA enforcement actions targeted bulk-compounding pharmacies that were producing HCG outside of strictly regulated 503B outsourcing facility rules. The enforcement was nominally aimed at safety. HCG is a complex glycoprotein that is hard to produce reliably without significant infrastructure. But its practical effect was to dramatically reduce the number of pharmacies willing to compound it.

Brand-name HCG (Pregnyl, Novarel) is still available, but it is expensive, requires a prescription, and goes through traditional pharmacy channels rather than the compounding pharmacies most TRT clinics work with.

The result: as of 2026, getting HCG through a typical online TRT clinic is hit-or-miss. Some clinics have stable supply chains; others have shifted entirely to gonadorelin, which serves a similar role through a different mechanism.

HCG vs. Gonadorelin: The 2026 Decision

Many men’s health clinics now ask: HCG or gonadorelin? Both serve a similar purpose, keeping the testicles functional during TRT. They work differently and have different practical profiles.

HCG mimics LH directly, binding to LH receptors in the testicles. Plasma terminal half-life is approximately 33-37 hours, but the biological effect on Leydig cell testosterone production persists 3-5 days after each injection – which is why 2-3x weekly dosing is sufficient.

Gonadorelin is synthetic GnRH (the upstream hormone). It tells the pituitary to release endogenous LH and FSH. Half-life is short (5-10 minutes), so it has to be dosed multiple times per day.

FactorHCGGonadorelin
Injections per week2-314-21 (2-3 daily)
Cost (compounded)$80-200/vial$80-200/vial
Availability (2026)Limited / inconsistentWidely compounded
Estrogen conversion potentialHigherLower
Effect on intratesticular testosteroneStrongModest
Pregnancy test interferenceYes (positive 7-14 days)No

Side Effects and Management

HCG at TRT-adjunct doses is generally well-tolerated. The side effects worth knowing about:

Water retention. HCG indirectly elevates aldosterone. Some men notice puffiness, especially in the face and ankles, in the first few weeks. Usually resolves or is manageable.

Estradiol elevation. Because HCG stimulates intratesticular testosterone production, and testosterone aromatizes to estradiol, your E2 can climb. Symptoms include nipple sensitivity, gynecomastia risk, mood changes, water retention. Standard management is to add an aromatase inhibitor like anastrozole at low doses (0.25-0.5 mg twice weekly) but only if E2 is genuinely elevated on bloodwork. Anastrozole abuse is its own problem; do not crush E2 just because you are worried.

Pregnancy test cross-reactivity. HCG is what home pregnancy tests detect. After an HCG injection, any pregnancy test you take will show positive for 7-14 days.

Drug interactions

Drug interactions to know

Moderate Menotropins / FSH preparations (Menopur, Gonal-F, Follistim)
How: Synergistic ovarian/testicular stimulation. hCG mimics LH activity; concurrent FSH stimulation in fertility protocols dramatically increases ovarian hyperstimulation syndrome (OHSS) risk, multifetal pregnancy, and arterial thromboembolism.
Pregnyl FDA label Warnings: 'The principal serious adverse reactions include ovarian hyperstimulation (a syndrome of sudden ovarian enlargement, ascites with or without pain, and/or pleural effusion), rupture of ovarian cysts with resultant hemoperitoneum, multiple births, and arterial thromboembolism.' Used clinically in combination but requires close monitoring with estradiol + transvaginal US.
Moderate Androgens / exogenous testosterone (testosterone cypionate, enanthate)
How: Both stimulate androgenic effects (hCG via Leydig-cell stimulation, exogenous T directly). Concurrent use compounds fluid retention, polycythemia, and androgenic side effects. Exogenous T suppresses endogenous LH and may blunt hCG-driven testicular response over time.
Pregnyl FDA label Precautions: 'Since androgens may cause fluid retention, HCG should be used with caution in patients with cardiac or renal disease, epilepsy, migraine, or asthma.' Class-effect concern; relevant to TRT-adjunct off-label use.
Moderate Anticoagulants (warfarin, DOACs — apixaban, rivaroxaban)
How: hCG-driven ovarian stimulation increases estradiol and shifts hemostatic balance toward thrombosis (OHSS-associated thromboembolism is a documented serious adverse reaction). Anticoagulants may need monitoring; estrogenic rise may also accelerate warfarin clearance.
Pregnyl FDA label Warnings names 'arterial thromboembolism' among principal serious adverse reactions. PMID 18460386 (Chan et al., thromboembolism with assisted reproduction).
Monitor Corticosteroids (prednisone, dexamethasone)
How: Both promote fluid retention; concurrent use compounds edema risk. Corticosteroids are also routinely co-prescribed in some fertility protocols and during OHSS management — interaction is bidirectional context-dependent.
Pregnyl Precautions: hCG androgenic fluid-retention warning. Class effect — not a contraindication.
Monitor Loop / thiazide diuretics (furosemide, hydrochlorothiazide)
How: hCG/androgen fluid retention may oppose diuretic effect; in OHSS management diuretics may be used cautiously due to intravascular volume depletion risk. Electrolyte monitoring (K+, Mg2+) prudent.
Pregnyl Precautions (cardiac/renal caution language). PMID 12372778 (Whelan & Vlahos, OHSS management review).
Moderate Aromatase inhibitors (anastrozole, letrozole) and SERMs (clomiphene, tamoxifen)
How: Co-administered intentionally in many fertility / TRT-adjunct protocols. Interaction is not adverse but pharmacodynamically intentional — letrozole/clomiphene drives endogenous FSH; hCG triggers ovulation or sustains Leydig-cell function. Listed to flag clinical awareness, not avoidance.
Standard ART/fertility protocols (PMID 20347429, Casper & Mitwally letrozole protocol). Pregnyl label does not list these as interactions but the combination defines current clinical practice.

Educational summary only, not medical advice. Consult your prescriber. See full interactions lookup.

Cycle Lengths

Cycling summary: Continuous per Endocrine Society TRT guideline (Bhasin 2018); 2-3x weekly SC, indefinite.

Chronic-use peptides like HCG are typically continued as long as the treatment goal is active. Intentional pauses may be indicated for pregnancy planning, scheduled surgery, or transition to maintenance dosing (peptide-specific). See the peptide’s FDA prescribing information or your prescribing clinician for personalized guidance.

Lab Monitoring

HCG is a research-tier peptide without an established peripheral efficacy biomarker. Lab monitoring should be prudent general-health surveillance rather than efficacy tracking. The panels below cover organ systems most relevant during peptide research use.

Baseline (before starting): CBC with differential, comprehensive metabolic panel (CMP) covering LFTs and renal function, fasting lipid panel, hs-CRP for inflammatory baseline, fasting glucose, and HbA1c if metabolic risk factors are present.

During use: repeat CMP + CBC every 8-12 weeks. Repeat hs-CRP alongside if using for inflammatory conditions to track the inflammatory read against symptom response. Watch trends in ALT/AST (liver) and eGFR (renal) rather than single readings.

What to flag to a physician: injection-site erythema or nodule formation, unexplained weight changes, new joint or mass symptoms, any lab value trending outside reference range across two consecutive draws.

For the full class-wide monitoring framework and a plain-language comparison of DTC lab services for peptide users, see the Peptide Lab Testing pillar guide.

Storage & Travel

Storage

Lyophilized powder: Room temperature 20-25°C (68-77°F); excursions 15-30°C (59-86°F) permitted.

Reconstituted: Novarel: refrigerate 2-8°C (36-46°F); use within 30 days. Pregnyl: refrigerate; use within 60 days. Never freeze a reconstituted vial, since freeze-thaw cycles damage peptide bonds and reduce potency.

Travel

Domestic flights: pack reconstituted vials in an insulated cooler with reusable ice packs. The TSA 3-1-1 rule limits liquids to 100 mL per container in carry-on; a 3-5 mL peptide vial passes with room to spare. Keep pharmacy or vendor documentation visible for TSA questions. Lyophilized powder in original sealed vial does not require cooling for short trips.

International travel: HCG is a research peptide in most jurisdictions with varying import restrictions — check the destination country’s rules before travel. Carry a physician’s letter if the peptide was prescribed by a compounding-focused clinician.

Road trips: keep the cooler in the cabin, not the trunk, during summer. Hotel mini-fridges vary in temperature stability; an insulated bag inside the mini-fridge adds a buffer.

Emergency out-of-fridge: reconstituted HCG at room temperature under 24 hours is generally still viable per USP stability guidance. Longer excursions or temperatures above 30°C compromise potency; discard and reconstitute a fresh vial.

Storage and Handling

HCG is fragile. Once reconstituted, the molecule degrades faster than most peptides.

  • After reconstitution: Refrigerate immediately. Use within 30 days for full potency.
  • Never freeze. Freezing damages the glycoprotein structure and reduces potency.
  • Bacteriostatic water only. Sterile water lacks the benzyl alcohol preservative, which dramatically reduces shelf life and increases contamination risk.
  • Use insulin syringes (U-100) for SC injection. Fine 29-31 gauge, 0.5″ length.

Cost

  • Compounded 5,000 IU vial: $80-200 (varies by pharmacy and region)
  • Compounded 10,000 IU vial: $150-350
  • Brand name (Pregnyl, Novarel): $200-500 per dose pack, prescription required

Frequently Asked Questions

What is HCG used for in TRT?

HCG is used alongside testosterone replacement therapy to maintain testicular size, preserve fertility, and prevent the cognitive/mood changes that some men experience on TRT alone. It mimics luteinizing hormone (LH) and keeps the testicles producing intratesticular testosterone.

What is the standard HCG dose for TRT?

The standard HCG dose for TRT adjunct use is 250-500 IU subcutaneous, 2-3 times per week. Specific dosing depends on individual response, fertility goals, and clinical supervision.

Is HCG dosed in mg or IU?

HCG is always dosed in International Units (IU), not milligrams. Confusing the two is the most common reconstitution error in self-administered HCG protocols.

Why is HCG hard to get in 2026?

FDA enforcement actions in 2024-2025 against bulk-compounding pharmacies significantly reduced HCG availability. Many TRT clinics have shifted to gonadorelin as an alternative.

HCG vs gonadorelin: which is better?

Both maintain testicular function during TRT. HCG works directly on the testicles; gonadorelin works through the pituitary. HCG is dosed 2-3x/week; gonadorelin is 2-3x/day. Gonadorelin is currently more available and produces less estrogen elevation. HCG produces stronger intratesticular testosterone support.

Can HCG cause a positive pregnancy test?

Yes. Home pregnancy tests detect HCG. After an HCG injection, you will test positive for approximately 7-14 days regardless of pregnancy status.

How long does reconstituted HCG last in the refrigerator?

Reconstituted HCG retains full potency for approximately 30 days when refrigerated. Beyond 30 days, potency degrades.

Bottom Line

HCG remains a high-value addition to TRT for the right person. It addresses the three biggest blind spots of testosterone-only therapy: testicular atrophy, fertility preservation, and the subtle “off” feeling some men experience.

The 2024-2026 supply crisis has made it harder to source, and gonadorelin has emerged as a practical alternative with its own pros and cons. If your clinic offers either, lean on their guidance, both work well when properly prescribed and dosed.

Whatever you take, get the math right. HCG dosed in IU, not mg. Reconstitution depends on your vial size and BAC water volume. Use the calculator to convert your prescribed dose into the correct mL on your insulin syringe, and verify with your prescribing physician before drawing any dose.

This article is for informational purposes only and does not constitute medical advice. HCG is a prescription medication. Consult your physician before starting, modifying, or discontinuing any hormone therapy.

Research-peptide buyer’s note (read before purchasing). Most HCG for TRT sold online is labeled “for research use only” and is not FDA-approved for human administration. If you choose to purchase research-grade product:
  • Demand a current third-party Certificate of Analysis (CoA) listing peptide identity (mass spec), purity ≥98%, and endotoxin testing.
  • Verify the lyophilized vial weight matches what is printed – under-filled vials are the most common form of dose-cheating in this market.
  • Storage: Glycoprotein hormone, not a small peptide. FDA-approved formulations exist.
  • Typical research route: subcutaneous or IM.
  • Pharmaceutical hCG (Pregnyl, Novarel) is the gold standard. Research-grade quality varies wildly.
  • “Research-use-only” labeling has legal weight – self-administration may violate state and federal law in your jurisdiction.

References

  • U.S. Food and Drug Administration. Pregnyl (chorionic gonadotropin) prescribing information. DailyMed.
  • U.S. Food and Drug Administration. Novarel (chorionic gonadotropin) prescribing information. DailyMed.
  • Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose hCG maintains intratesticular testosterone in men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90(5):2595-2602. PubMed.
  • Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular hCG preserves spermatogenesis in men undergoing TRT. J Urol. 2013;189(2):647-650. PubMed.
  • Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PubMed.
  • U.S. Food and Drug Administration. FDA approval history for chorionic gonadotropin products. Drugs@FDA.
  • World Anti-Doping Agency. Prohibited List 2026, Section S2 (hCG prohibited in male athletes). WADA.
Educational use only. This article is informational and does not constitute medical advice. Peptide dosing decisions should be made in consultation with a licensed physician familiar with your medical history. Always verify any dose with your prescribing physician before drawing or administering. Some peptides discussed are not FDA-approved for human use; legal and regulatory status varies by jurisdiction.

Quick answer: The standard TRT-adjunct HCG dose is 250-500 IU subcutaneous, 2-3 times per week, alongside testosterone replacement therapy. TRT users take HCG to maintain testicular size, preserve fertility, and prevent the mood/cognitive symptoms some men experience when testicular function shuts down on TRT alone.

Important: HCG is dosed in International Units (IU), not milligrams. Confusing the two is the most common reconstitution error and can lead to dosing errors of 100x or more.

The 2026 reality: HCG has become significantly harder to source through compounding pharmacies since FDA enforcement actions in 2024-2025. Many TRT clinics have switched patients to gonadorelin as a result.

FDA status: HCG itself is FDA-approved (brand names: Pregnyl, Novarel) for hypogonadotropic hypogonadism in males, ovulation induction in females, and cryptorchidism in pediatric patients. Use as a TRT adjunct (the focus of this article) is off-label, supported by a long history of clinical practice but not on the FDA-approved label.

Stay current on peptide research.

Monthly updates on FDA reclassification news, new dosing protocols, and calculator features. No spam, unsubscribe anytime.

Peptide updates + FDA alerts

Monthly peptide updates and important FDA alerts. No spam, unsubscribe anytime.

Join peptide patients and biohackers getting research updates straight to their inbox.

Similar Posts